IMC Chicago’s AstraZeneca AZN Stock Holding History

IMC Chicago’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Buy	+7,754	New	+$1.46M	﹤0.01%	3388
2025 Q4	–	Sell	-20,753	Closed	-$3.64M	–	4062
2025 Q3	$3.18M	Sell	20,753 -1,196	-5%	-$181K	﹤0.01%	1912
2025 Q2	$3.07M	Buy	+21,949	New	+$3.08M	﹤0.01%	1720
2024 Q2	–	Sell	-5,041	Closed	-$759K	–	2620
2024 Q1	$683K	Buy	+5,041	New	+$668K	﹤0.01%	1905
2021 Q1	–	Sell	-28,293	Closed	-$2.84M	–	1037
2020 Q4	$2.83M	Buy	+28,293	New	+$3M	﹤0.01%	666

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

IMC Chicago's AZN Position: Q2 2026 in Review

IMC Chicago opened a new position in AstraZeneca (AZN) in Q2 2026: 7,754 shares worth $1.47M. The stake represents ﹤0.01% of the portfolio and ranks #3388 among its holdings. This is a return to the name: IMC Chicago previously reported a position in AZN as recently as Q3 2025.

IMC Chicago first reported a position in AZN in Q4 2020 and has held it in 5 quarters since. The position peaked at $3.18M in Q3 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

IMC Chicago held 7,754 shares of AstraZeneca worth $1.47M as of Q2 2026.
AstraZeneca was a new IMC Chicago position in Q2 2026.
AstraZeneca made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3388 holding.
IMC Chicago first reported a position in AstraZeneca in Q4 2020 and has held it in 5 quarters since.
IMC Chicago's AstraZeneca position peaked at $3.18M in Q3 2025.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.